(1)
Almaaytah, A.; Elhajji, F. D. Comparative Cost Efficiency of the Originator Drug of Infliximab and Its Biosimilar for the Treatment of Rheumatoid Arthritis in the MENA Region. ijpi 2019, 9, 12-15.